Apostolia M. Tsimberidou

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.477Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers

Data in Brief(2023)10.1016/j.dib.2023.109698

Top 40%

0.477DataRank

Top 40%4 citations

Henry Hiep Vo, Peter Müeller, Razelle Kurzrock, Apostolia M. Tsimberidou, Elena Fountzilas

Papers

Driven by 61 papers — median percentile 60. Top paper: “Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials”.

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature Medicine(2023)10.1038/s41591-022-02103-8

N/A

4.3DataRank · unranked

388 citations

Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric‐Bernstam +44 more

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000347

N/A

4.0DataRank · unranked

131 citations

Funda Meric‐Bernstam, Bettzy Stephen, Daniel D. Karp, Joud Hajjar, Jordi Rodon Ahnert +35 more

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Journal of Clinical Oncology(2022)10.1200/jco.22.00830

N/A

2.2DataRank · unranked

97 citations

Shuyang Yao, Yuan Yuan, Rebecca A. Previs, Anthony Elias, Richard D. Carvajal +15 more

Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors

The Oncologist(2021)10.1002/onco.13682

N/A

1.4DataRank · unranked

47 citations

Henry Hiep Vo, Vivek Subbiah, Filip Jankú, Sarina A. Piha‐Paul, Bülent Yılmaz +7 more

Precision Oncology: Evolving Clinical Trials across Tumor Types

Cancers(2023)10.3390/cancers15071967

N/A

1.3DataRank · unranked

61 citations

Henry Hiep Vo, Ying-Shiuan Chen, Mehmet A. Baysal, Michael Kahle, Amber Johnson +2 more

Review of precision cancer medicine: Evolution of the treatment paradigm

Cancer Treatment Reviews(2020)10.1016/j.ctrv.2020.102019

N/A

0.996DataRank · unranked

762 citations

Elena Fountzilas, Mina Nikanjam, Razelle Kurzrock, Apostolia M. Tsimberidou

Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2920

N/A

0.977DataRank · unranked

49 citations

David Vining, Sukeshi Patel Arora, Sofia de Achaval, Jeffrey Larson, John Kauh +6 more

Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0260

N/A

0.943DataRank · unranked

37 citations

Niamh Coleman, Sarina A. Piha‐Paul, Apostolia M. Tsimberidou, Filip Jankú, Jordi Rodón +13 more

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008668

N/A

0.742DataRank · unranked

29 citations

Tobias A.W. Holderried, Jason J. Luke, Van K. Morris, Winfried Alsdorf, Katrin Wetzko +27 more

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3629

N/A

0.719DataRank · unranked

21 citations

Justin T. Moyers, Jason Roszik, Shiraj Sen, David S. Hong, Aung Naing +29 more

Transcriptomics and solid tumors: The next frontier in precision cancer medicine

Seminars in Cancer Biology(2020)10.1016/j.semcancer.2020.09.007

N/A

0.704DataRank · unranked

108 citations

Elena Fountzilas, Leonidas Bleris, Razelle Kurzrock, Apostolia M. Tsimberidou

Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy

Journal of Hematology & Oncology(2023)10.1186/s13045-023-01504-7

N/A

0.663DataRank · unranked

82 citations

Börje S. Andersson, Mehmet A. Baysal, Jason S. Damiano, Apostolia M. Tsimberidou, Yannick Bulliard

Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0444

N/A

0.656DataRank · unranked

14 citations

Kerstin Guenther, Börje S. Andersson, Regina Mendrzyk, Amir Alpert, Claudia Wagner +36 more

Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3018

N/A

0.619DataRank · unranked

16 citations

David Vining, Sukeshi Patel Arora, Sofia de Achaval, Jeffrey Larson, Carrie Cartwright +4 more

Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology

npj Precision Oncology(2022)10.1038/s41698-022-00317-0

N/A

0.607DataRank · unranked

17 citations

Siqing Fu, David S. Hong, Daniel D. Karp, Sarina A. Piha‐Paul, Vivek Subbiah +18 more

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial

Nature Medicine(2025)10.1038/s41591-025-03650-6

N/A

0.601DataRank · unranked

54 citations

Dejka M. Araujo, Manik Chatterjee, Apostolia M. Tsimberidou, Tobias A.W. Holderried, Amir A. Jazaeri +35 more

Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies

British Journal of Cancer(2021)10.1038/s41416-020-01230-8

N/A

0.568DataRank · unranked

43 citations

Filip Jankú, Vivek Subbiah, John Stewart, Sapna P. Patel, Ahmed O. Kaseb +10 more

PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers

ESMO Open(2021)10.1016/j.esmoop.2021.100230

N/A

0.564DataRank · unranked

42 citations

S. Greg Call, Helen J. Huang, A.L. Stuckett, Kiran Madwani, Abha Adat +16 more

Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care

JCO Oncology Practice(2024)10.1200/op.23.00601

N/A

0.533DataRank · unranked

34 citations

Anthony Sireci, Robert Dumanois, Daryl Pritchard, Apostolia M. Tsimberidou

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

The Oncologist(2024)10.1093/oncolo/oyad338

N/A

0.510DataRank · unranked

29 citations

Binghe Xu, Ecaterina E. Dumbrava, Siqing Fu, Daniel D. Karp, Funda Meric‐Bernstam +20 more

Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study

npj Precision Oncology(2021)10.1038/s41698-021-00159-2

N/A

0.505DataRank · unranked

28 citations

David S. Hong, Siqing Fu, Daniel D. Karp, Sarina A. Piha‐Paul, Merrill S. Kies +16 more

Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences

Scientific Reports(2022)10.1038/s41598-022-12669-5

N/A

0.483DataRank · unranked

24 citations

Funda Meric‐Bernstam, David S. Hong, Filip Jankú, Aung Naing, Sarina A. Piha‐Paul +13 more

Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers

Data in Brief(2023)10.1016/j.dib.2023.109698

Top 40%

0.477DataRank

Top 40%4 citations

Henry Hiep Vo, Peter Müeller, Razelle Kurzrock, Apostolia M. Tsimberidou, Elena Fountzilas

Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer

BMJ Oncology(2024)10.1136/bmjonc-2023-000133

N/A

0.473DataRank · unranked

13 citations

Genevieve Hartley, Coline Couillault, Ying Yuan, Heather Lin, Courtney Nicholas +18 more

BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study

npj Precision Oncology(2023)10.1038/s41698-022-00341-0

N/A

0.470DataRank · unranked

22 citations

Jason Roszik, Filip Jankú, David S. Hong, Shumei Kato, Aung Naing +11 more

Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies

Scientific Reports(2020)10.1038/s41598-020-58366-z

N/A

0.464DataRank · unranked

21 citations

Filip Jankú, Sarina A. Piha‐Paul, Kenneth R. Hess, Russell R. Broaddus, Lidong Liu +11 more

A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors

The Oncologist(2023)10.1093/oncolo/oyad158

N/A

0.438DataRank · unranked

10 citations

Apostolia M. Tsimberidou, Xueyao Fu, Siqing Fu, Vivek Subbiah, Anil K. Sood +7 more

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

Cancer(2023)10.1002/cncr.35063

N/A

0.434DataRank · unranked

17 citations

Jibran Ahmed, Bettzy Stephen, Sarina A. Piha‐Paul, Daniel D. Karp, Abdulrazzak Zarifa +13 more

Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series

Therapeutic Advances in Medical Oncology(2021)10.1177/17588359211001538

N/A

0.412DataRank · unranked

9 citations

Henry Hiep Vo, David Vining, Apostolia M. Tsimberidou, Mohammad Faraz Naqvi

Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.004

N/A

0.385DataRank · unranked

8 citations

Siqing Fu, Apostolia M. Tsimberidou, Sarina A. Piha‐Paul, Fechukwu Akhmedzhanov, Bülent Yılmaz +16 more

Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial

Scientific Reports(2022)10.1038/s41598-022-16588-3

N/A

0.375DataRank · unranked

4 citations

David S. Hong, Christine B. Peterson, Bettzy Stephen, Ecaterina E. Dumbrava, Shubbam Pant +18 more

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi -NT in Patients with Advanced Solid Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3952

N/A

0.330DataRank · unranked

8 citations

Filip Jankú, Siqing Fu, Ecaterina E. Dumbrava, David S. Hong, Daniel D. Karp +20 more

Synergistic Cytotoxicity of Histone Deacetylase and Poly-ADP Ribose Polymerase Inhibitors and Decitabine in Breast and Ovarian Cancer Cells: Implications for Novel Therapeutic Combinations

International Journal of Molecular Sciences(2024)10.3390/ijms25179241

N/A

0.330DataRank · unranked

8 citations

Apostolia M. Tsimberidou, Bin Yuan, Mehmet A. Baysal, Abhijit Chakraborty, Clark R. Andersen +2 more

Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies

npj Precision Oncology(2023)10.1038/s41698-023-00369-w

N/A

0.312DataRank · unranked

7 citations

Roman Groisberg, Ralph Zinner, Andrew W. Hahn, Aung Naing, Shizhen Zhang +16 more

Targeting Oxidative Phosphorylation with a Mitochondrial Complex I Inhibitor is limited by Mechanism-based Toxicity

Research Square(2022)10.21203/rs.3.rs-1506700/v1

N/A

0.269DataRank · unranked

5 citations

Timothy A. Yap, Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka +43 more

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer

Cancer(2023)10.1002/cncr.34773

N/A

0.269DataRank · unranked

5 citations

Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina A. Piha‐Paul, Julia Ann Moore +18 more

Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors

The Oncologist(2025)10.1093/oncolo/oyaf169

N/A

0.241DataRank · unranked

4 citations

Farshid Dayyani, David Sommerhalder, Andrae Lavon Vandross, Meredith S. Pelster, Jason T. Henry +9 more

Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2564

N/A

0.241DataRank · unranked

4 citations

Matthew J. Reilley, Amadeo B. Biter, JoAnn Lim, Stacie A. Bean, Ly M. Nguyen +14 more

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial

Journal of Immunotherapy and Precision Oncology(2025)10.36401/jipo-24-17

N/A

0.217DataRank · unranked

3 citations

Mohamed A. Gouda, Matthew J. Reilley, Amadeo B. Biter, JoAnn Lim, Stacie A. Bean +15 more

Biomarkers and Outcomes in Diverse Cancers: Meta-Analysis of Early Phase Immuno-Oncology Trials

Research Square(2022)10.21203/rs.3.rs-2386222/v1

N/A

0DataRank · unranked

0 citations

Henry Hiep Vo, Peter Müeller, Razelle Kurzrock, Apostolia M. Tsimberidou, Elena Fountzilas

AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology

Cell & Bioscience(2022)10.1186/s13578-022-00793-8

N/A

0DataRank · unranked

22 citations

Antonis Skliris, Alan Valentine, Jamie Shaw, Ursula Hering, Henry Hiep Vo +6 more

Enhancing the Efficacy of CAR-T Cell Therapy: A Comprehensive Exploration of Cellular Strategies and Molecular Dynamics

Journal of Cancer Immunology(2024)10.33696/cancerimmunol.6.080

N/A

0DataRank · unranked

5 citations

Abhijit Chakraborty, Apostolia M. Tsimberidou, Mehmet A. Baysal

Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy

Frontiers in Immunology(2024)10.3389/fimmu.2024.1366271

N/A

0DataRank · unranked

4 citations

Mehmet A. Baysal, Abhijit Chakraborty, Becky Norris, Fareed Khawaja, Apostolia M. Tsimberidou +1 more

Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology(2024)10.1007/s00280-024-04714-z

N/A

0DataRank · unranked

2 citations

Axel Grothey, Darren Sigal, Heinz-Josef Lenz, Howard S. Höchster, Yee Chao +5 more

Metastatic extraneural glioblastoma diagnosed with molecular testing

The Oncologist(2024)10.1093/oncolo/oyae115

N/A

0DataRank · unranked

1 citations

Henry Hiep Vo, César A. Moran, Shiao‐Pei Weathers, I-Wen Song, Garret Williford +4 more

Convergence of evolving artificial intelligence and machine learning techniques in precision oncology

npj Digital Medicine(2025)10.1038/s41746-025-01471-y

N/A

0DataRank · unranked

164 citations

Tillman Pearce, Mehmet A. Baysal, Abhijit Chakraborty, Apostolia M. Tsimberidou, Elena Fountzilas

Developments in nanotechnology approaches for the treatment of solid tumors

Experimental Hematology and Oncology(2025)10.1186/s40164-025-00656-1

N/A

0DataRank · unranked

80 citations

Abhijit Chakraborty, Mehmet A. Baysal, Apostolia M. Tsimberidou, Jacopo Venturini

Selinexor in combination with weekly paclitaxel in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multiarm phase 1b study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5565

N/A

0DataRank · unranked

0 citations

Siqing Fu, Apostolia M. Tsimberidou, Sarina A. Piha‐Paul, Fechukwu Akhmedzhanov, Bülent Yılmaz +15 more

Patients with advanced solid cancers treated with ERK inhibitors exhibit pseudo-progession in lymphatic nodes.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3138

N/A

0DataRank · unranked

0 citations

Daniel D. Karp, Abha Adat, Timothy A. Yap, Siqing Fu, Jordi Rodon Ahnert +12 more

A phase 2 basket study of talabostat, a small‐molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers

Cancer(2025)10.1002/cncr.35728

N/A

0DataRank · unranked

4 citations

Filip Janku, Daniel D. Karp, Sarina A. Piha‐Paul, Apostolia M. Tsimberidou, Timothy A. Yap +8 more

EphA2 siRNA in DOPC nanoliposomes (EPHARNA): A phase I clinical trial in patients with solid tumors.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.3086

N/A

0DataRank · unranked

0 citations

Aung Naing, Gabriel Lopez‐Berestein, Cristian Rodríguez-Aguayo, Hassan Ahmed Momin, Anupama Madhyannapu +11 more

Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case series

npj Precision Oncology(2025)10.1038/s41698-025-01115-0

N/A

0DataRank · unranked

0 citations

Mohamed A. Gouda, Apostolia M. Tsimberidou, Camila Bragança Xavier

532 A phase 1 dose escalation and dose expansion trial of NP-101 in patients with advanced solid tumors

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0532

N/A

0DataRank · unranked

0 citations

Bettzy Stephen, Serdar A. Gurses, Michelle York Gocio, Mohamed Omar Kaseb, Yali Yang +18 more

Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies: safety, efficacy, and ovarian cancer expansion

The Oncologist(2025)10.1093/oncolo/oyaf413

N/A

0DataRank · unranked

0 citations

Chieh Tseng, Emily Thompson, R. Jason Stafford, Hung Le, Lei Kang +12 more

Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab067

N/A

0DataRank · unranked

48 citations

Razelle Kurzrock, Henry Hiep Vo, Apostolia M. Tsimberidou, Elena Fountzilas

Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer

Journal of Immunotherapy and Precision Oncology(2023)10.36401/jipo-22-23

N/A

0DataRank · unranked

1 citations

Heather Lin, Siqing Fu, Amadeo B. Biter, Ecaterina E. Dumbrava, Daniel D. Karp +15 more

Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non–small-cell Lung Cancer

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.05.029

N/A

0DataRank · unranked

12 citations

Sheryl K. Elkin, Robert Dumanois, Daryl Pritchard, Apostolia M. Tsimberidou

Autologous engineered T cell receptor therapy in advanced cancer

Human Vaccines & Immunotherapeutics(2023)10.1080/21645515.2023.2290356

N/A

0DataRank · unranked

5 citations

Mehmet A. Baysal, Abhijit Chakraborty, Börje S. Andersson, Apostolia M. Tsimberidou

Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design

Cancer Treatment Reviews(2024)10.1016/j.ctrv.2024.102703

N/A

0DataRank · unranked

22 citations

Apostolia M. Tsimberidou, Henry Hiep Vo, Razelle Kurzrock, Elena Fountzilas

Baseline symptom, health status, and health utilities in patients in early-phase clinical trials combining immune checkpoint blockade with other anticancer therapies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12117

N/A

0DataRank · unranked

0 citations

Sarina A. Piha‐Paul, Siqing Fu, Jordi Rodon Ahnert, Timothy A. Yap, Vivek Subbiah +10 more

Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials

European Journal of Cancer(2023)10.1016/j.ejca.2023.05.015

N/A

0DataRank · unranked

19 citations

Henry Hiep Vo, Peter Müeller, Razelle Kurzrock, Apostolia M. Tsimberidou, Elena Fountzilas

Apostolia M. Tsimberidou

Indexed papers

Top data-sharing exemplar

Papers